News round up 9 October 2017
Posted on 09 October, 2017 by Thierry Heles, editor
A round up of all the latest news on www.globalgovernmentventuring.com for our subscribers.
Dewost, a former head at CDC, said: "With Leonard, Vinci is offering me a chance to contribute to the digital transformation of durable structures and move from bytes to concrete.
The artificial intelligence and data science-focused hub will aim to support 35,000 new jobs within five years.
Vietnam startups currently attract VC investments of between $5,000 and $50,000, but no regulatory framework exists to provide clarity for investors.
The vehicle will aim to commercialise local startups and spinouts from Temasek Life Sciences Laboratory, a division of the firm's philanthropic arm Temasek Trust.
African Development Bank is a limited partner in the $200m Rx Healthcare Fund, which will back companies that can help improve healthcare in Africa.
The vehicle is part of a $10bn agreement struck between RDIF and Public Investment Fund in 2015 which seeks to invest in Russian businesses.
The latest competitive start fund will aim to lure seasoned business figures to redress the ecosystem’s imbalance that has favoured younger founders.
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
Advanced robotics developer Kinova will use the funding to support an international expansion and lobby healthcare regulators to permit medical robotic products.
Bpifrance has reinvested in the fintech developer as Long Arc Capital acquired a majority stake.
The biopharmaceutical developer has opened an office in the US with the extension, which followed a first close backed by HTGF and KfW.
Automated robotics developer Kryon will use the capital to complete a software product for enterprises and to mount an expansion into international markets.
Nanotronics’ total funding now stands at $71m and the company will use its latest round to expand in Asia and further develop its advanced microscopes.
The money will be used to expand Recursion’s drug discovery program, which uses machine-learning to rapidly collect data for a diverse range of diseases.
Vertex is among the investors in Visterra’s series C round, which has now closed at $46.7m following a $23.6m second tranche.
GV-backed online travel marketplace Secret Escapes has collected $111m in equity and debt financing from investors including Singapore state-owned Temasek.
Palleon Pharmaceuticals has launched with $47.6m in series A funding to commercialise cancer therapies based on technology developed at Stanford and Dundee universities.
The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.
Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.
Latest magazinePast Issues
Get full online access, the monthly magazine, weekly news alerts, special reports and more.See all subscription options